Newsmeme!
Discover News you didn't know existed
Cardiovascular disease (commonly referred to as heart disease) is the leading cause of death for women worldwide. Almost every minute, a woman in the U.S. dies from heart disease. Despite the prevalence of heart disease in women, a 2005 American Heart Association study showed that 92% of primary care physicians and 83% of cardiologists were not aware of the fact that more women than men die of ...
AstraZeneca (NYSE: AZN) announced that the US Food and Drug Administration (FDA) has approved CRESTOR® (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction (heart attack) and arterial revascularization procedures in individuals without clinically evident coronary heart disease but with an increased risk of cardiovascular disease (CVD) based on age (men 50 and over, women 60 ...
Cardiovascular disease is the leading cause of death for women worldwide. Almost every minute, a woman in the U.S. dies from heart disease. Despite the prevalence of heart disease in women, a 2005 American Heart Association study showed that 92% of primary care physicians and 83% of cardiologists were not aware of the fact that more women than men die of heart disease each year.
Tuesday, President Barack Obama created a task force of Cabinet secretaries and other officials and gave them 90 days to come up with a grand strategy to combat childhood obesity. More health news
Dr Kalapatapu is a fellow in the department of addiction psychiatry at Columbia University, New York State Psychiatric Institute, New York. He completed a fellowship in geriatric psychiatry at the Mount Sinai School of Medicine in New York in July 2009. The author reports no conflicts of interest concerning the subject matter of this article and has declined the honorarium for this article.
JAMA. 2010;303(6):559-560. Adolescent obesity is a vexing problem for which there are few good solutions. Obese children develop metabolic syndrome.
SAN DIEGO----Ligand Pharmaceuticals Incorporated today announced financial results for the three and 12 months ended December 31, 2009, and reviewed business highlights of the fourth quarter of 2009 and early 2010.
UK- AstraZeneca's CRESTOR gets FDA approval for use
Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating R
AstraZeneca today announced that the US Food and Drug Administration has approved CRESTOR® to reduce the risk of stroke, myocardial infarction and arterial revascularization procedures in individuals without clinically evident coronary heart disease but with an increased risk of cardiovascular disease based on age , high-sensitivity C-reactive protein greater than or equal to 2 mg/L, and the ...
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |